Continuous Glucose Monitoring Market Scope And Analysis

Report Code : TIPRE00018031
Category : Medical Device

No. of Pages : 150

Buy Now

Continuous Glucose Monitoring Device (CGMD) Market Analysis, Size, and Growth (2021-2022)

Buy Now

Continuous Glucose Monitoring Device (CGMD) Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 9.8 Billion
Market Size by 2030	US$ 28.5 Billion
Global CAGR (2022 - 2030)	14.1%
Historical Data	2020-2022
Forecast period	2022-2030
Segments Covered	By Product Sensors Transmitters Receivers By Application Type 1 Diabetes and Type 2 Diabetes By Testing Site Fingertip Testing and Alternate Site Testing By End User Hospitals & Clinics and Self/Homecare
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	B Braun SE F Hoffmann La Roche Ltd LifeScan Inc Medtronic Abbott Laboratories Ypsomed Holding AG Sensionics Nipro Corp GE Healthcare

Industry Developments and Future Opportunities:

A few strategic developments by leading players operating in the Continuous Glucose Monitoring Device market, as per their press releases, are listed below:

In October 2023, Philips-Medisize announced a partnership with GlucoModicm to commercialize a proprietary noninvasive and wearable device. The partnership is aimed at creating a solution that is needle-free, accurate, and more affordable for diabetic people seeking ways to monitor blood glucose levels better.
In January 2024, Medtronic, announced CE Mark approval for the "MiniMed 780G system" with the Simplera Sync, a disposable, all-in-one Continuous Glucose Monitoring Device seeking no finger prick or overtape. The new product will be available in Europe and Medtronic had a phased commercial launch in Europe in Spring 2024.
In December 2023, Dexcom announced a new Continuous Glucose Monitoring Device product launch, "Dexcom G7" " The new product launch is the smallest and most accurate Continuous Glucose Monitoring Device connected to the t: slim X2 insulin pump. The product is the fastest Continuous Glucose Monitoring Device connected to the t: slim X2 pump with a 30-minute sensor warmup,* and along with Dexcom G6, and is the only Continuous Glucose Monitoring Device system providing alert seeking no finger prick.

Competitive Landscape and Key Companies:

B. Braun SE, F. Hoffmann-La-Roche Ltd, LifeScan Inc, Medtronic, Abbott Laboratories, Ypsomed Holding AG, Sensionics, Nipro Corp, GE Healthcare, and Terumo Corp are among the prominent companies profiled in the Continuous Glucose Monitoring Device market report. These companies focus on developing new technologies, upgrading existing products, and expanding their geographic presence to meet the growing consumer demand worldwide.